Citation: Y. Yoshiyama et al., PROTECTIVE EFFECT OF CEFTRIAXONE AGAINST THE NEPHROTOXICITY OF ISEPAMICIN ADMINISTERED ONCE-DAILY IN RATS, Biological & pharmaceutical bulletin, 21(5), 1998, pp. 520-523
Authors:
WASHINGTON K
CHIAPPORI A
HAMILTON K
SHYR Y
BLANKE C
JOHNSON D
SAWYERS J
BEAUCHAMP D
Citation: K. Washington et al., EXPRESSION OF BETA-CATENIN, ALPHA-CATENIN, AND E-CADHERIN IN BARRETTS-ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMAS, Modern pathology, 11(9), 1998, pp. 805-813
Citation: D. Beauchamp et Mg. Bergeron, PHARMACOLOGICAL PRINCIPLES OF PYELONEPHRITIS TREATMENT - DISTRIBUTION, EFFICIENCY AND RENAL TOXICITY OF ANTIBIOTICS, MS. Medecine sciences, 13(8-9), 1997, pp. 942-951
Authors:
LUAN J
SHATTUCKBRANDT R
HAGHNEGAHDAR H
OWEN JD
STRIETER R
BURDICK M
NIRODI C
BEAUCHAMP D
NEWSOM K
RICHMOND A
Citation: J. Luan et al., MECHANISM AND BIOLOGICAL SIGNIFICANCE OF CONSTITUTIVE EXPRESSION OF MGSA GRO CHEMOKINES IN MALIGNANT-MELANOMA TUMOR PROGRESSION/, Journal of leukocyte biology, 62(5), 1997, pp. 588-597
Authors:
BEAUCHAMP D
GUIMONT C
GRENIER L
LEBRUN M
TARDIF D
GOURDE P
BERGERON MG
THIBAULT L
LABRECQUE G
Citation: D. Beauchamp et al., TIME-RESTRICTED FEEDING SCHEDULES MODIFY TEMPORAL VARIATION OF GENTAMICIN EXPERIMENTAL NEPHROTOXICITY, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1468-1474
Authors:
BEAUCHAMP D
LAURENT G
GRENIER L
GOURDE P
ZANEN J
HEUSONSTIENNON JA
BERGERON MG
Citation: D. Beauchamp et al., ATTENUATION OF GENTAMICIN-INDUCED NEPHROTOXICITY IN RATS BY FLEROXACIN, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1237-1245
Authors:
TURCOTTE A
SIMARD M
MORIN NJ
BEAUCHAMP D
BERGERON MG
Citation: A. Turcotte et al., DIFFERENTIAL DISTRIBUTIONS IN TISSUES AND EFFICACIES OF AZTREONAM ANDCEFTAZIDIME AND IN-VIVO BACTERIAL MORPHOLOGICAL-CHANGES FOLLOWING TREATMENT, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 401-409
Authors:
OMAR RF
HARVIE P
GOURDE P
DESORMEAUX A
TREMBLAY M
BEAUCHAMP D
BERGERON MG
Citation: Rf. Omar et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL, Toxicology and applied pharmacology, 143(1), 1997, pp. 140-151
Citation: D. Beauchamp et E. Hardy, THE STELLAR POPULATIONS OF SPIRAL DISKS .1. A NEW OBSERVATIONAL APPROACH - DESCRIPTION OF THE TECHNIQUE AND SPECTRAL GRADIENTS FOR THE INTER-ARM REGIONS OF NGC-4321 (M100), The Astronomical journal, 113(5), 1997, pp. 1666-1677
Authors:
HARVIE P
OMAR RF
DUSSERRE N
DESORMEAUX A
GOURDE P
TREMBLAY M
BEAUCHAMP D
BERGERON MG
Citation: P. Harvie et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 451-461
Authors:
LIN LS
GRENIER L
LEBRUN M
BERGERON MG
THIBAULT L
LABRECQUE G
BEAUCHAMP D
Citation: Ls. Lin et al., DAY-NIGHT TREATMENT DIFFERENCE OF TOBRAMYCIN SERUM AND INTRARENAL DRUG DISTRIBUTION AND NEPHROTOXICITY IN RATS - EFFECTS OF FASTING, Chronobiology international, 13(2), 1996, pp. 113-121
Authors:
BEAUCHAMP D
COLLIN P
GRENIER L
LEBRUN M
COUTURE M
THIBAULT L
LABRECQUE G
BERGERON MG
Citation: D. Beauchamp et al., EFFECTS OF FASTING ON TEMPORAL VARIATIONS IN NEPHROTOXICITY OF GENTAMICIN IN RATS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 670-676
Authors:
YOSHIYAMA Y
GRENIER L
GOURDE P
SIMARD M
LIN LS
MORIN NJ
BERGERON MG
LABRECQUE G
BEAUCHAMP D
Citation: Y. Yoshiyama et al., TEMPORAL VARIATION IN NEPHROTOXICITY OF LOW-DOSES OF ISEPAMICIN IN RATS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 802-806
Authors:
HARVIE P
DESORMEAUX A
BERGERON MC
TREMBLAY M
BEAUCHAMP D
POULIN L
BERGERON MG
Citation: P. Harvie et al., COMPARATIVE PHARMACOKINETICS, DISTRIBUTIONS IN TISSUE, AND INTERACTIONS WITH BLOOD PROTEINS OF CONVENTIONAL AND STERICALLY STABILIZED LIPOSOMES CONTAINING 2',3'-DIDEOXYINOSINE, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 225-229
Authors:
OMAR RF
GOURDE P
DESORMEAUX A
TREMBLAY M
BEAUCHAMP D
BERGERON MG
Citation: Rf. Omar et al., IN-VIVO TOXICITY OF FOSCARNET AND ZIDOVUDINE GIVEN ALONE OR IN COMBINATION, Toxicology and applied pharmacology, 139(2), 1996, pp. 324-332
Authors:
HARVIE P
OMAR RF
DUSSERRE N
LANSAC N
DESORMEAUX A
GOURDE P
SIMARD M
TREMBLAY M
BEAUCHAMP D
BERGERON MG
Citation: P. Harvie et al., RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 1009-1017
Authors:
EID P
WONG PTT
LACELLE S
BERGERON MG
BEAUCHAMP D
CARRIER D
Citation: P. Eid et al., EFFECT OF DAPTOMYCIN ON THE BAROTROPIC BEHAVIOR OF DIOLEOYLPHOSPHATIDYLGLYCEROL - AN INFRARED SPECTROSCOPIC INVESTIGATION, Chemistry and physics of lipids, 83(2), 1996, pp. 131-140
Authors:
DELOCHE G
HANNEQUIN D
CARLOMAGNO S
AGNIEL A
DORDAIN M
PASQUIER F
PELLAT J
DENIS P
DESI M
BEAUCHAMP D
METZLUTZ MN
CESARO P
SERON X
Citation: G. Deloche et al., CALCULATION AND NUMBER PROCESSING IN MILD ALZHEIMERS-DISEASE, Neuropsychology, development, and cognition. Section A, Journal of clinical and experimental neuropsychology, 17(4), 1995, pp. 634-639
Authors:
MAKABIPANZU B
LESSARD C
BEAUCHAMP D
DESORMEAUX A
POULIN L
TREMBLAY M
BERGERON MG
Citation: B. Makabipanzu et al., UPTAKE AND BINDING OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE BY RAW-264.7 CELLS - A 3-STEP PROCESS, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 227-235
Authors:
LIN LS
GRENIER L
GUIMONT C
LEBRUN M
LABRECQUE G
BERGERON MG
BEAUCHAMP D
Citation: Ls. Lin et al., CIRCADIAN VARIATION IN THE INTRACORTICAL ACCUMULATION KINETICS OF TOBRAMYCIN IN CONSCIOUS RATS, Chronobiology international, 12(3), 1995, pp. 188-194
Authors:
DUSSERRE N
LESSARD C
BEAUCHAMP D
DESORMEAUX A
POULIN L
TREMBLAY M
BERGERON MG
Citation: N. Dusserre et al., LIPOSOMAL ENCAPSULATION DELIVERS FOSCARNET (PFA) TO SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND IMPROVES ITS PHARMACOKINETICS, Journal of cellular biochemistry, 1995, pp. 177-177
Authors:
DUSSERRE N
LESSARD C
PAQUETTE N
PERRON S
POULIN L
TREMBLAY M
BEAUCHAMP D
DESORMEAUX A
BERGERON MG
Citation: N. Dusserre et al., ENCAPSULATION OF FOSCARNET IN LIPOSOMES MODIFIES DRUG INTRACELLULAR ACCUMULATION, IN-VITRO ANTI-HIV-1 ACTIVITY, TISSUE DISTRIBUTION AND PHARMACOKINETICS, AIDS, 9(8), 1995, pp. 833-841